Dysfunction in the Cystic Fibrosis Transmembrane Regulator in Chronic Obstructive Pulmonary Disease as a Potential Target for Personalised Medicine

In recent years, numerous pathways were explored in the pathogenesis of COPD in the quest for new potential therapeutic targets for more personalised medical care. In this context, the study of the cystic fibrosis transmembrane conductance regulator (CFTR) began to gain importance, especially since...

Descripción completa

Detalles Bibliográficos
Autores principales: Carrasco-Hernández, Laura, Quintana-Gallego, Esther, Calero, Carmen, Reinoso-Arija, Rocío, Ruiz-Duque, Borja, López-Campos, José Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533244/
https://www.ncbi.nlm.nih.gov/pubmed/34680554
http://dx.doi.org/10.3390/biomedicines9101437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533244/
https://www.ncbi.nlm.nih.gov/pubmed/34680554
http://dx.doi.org/10.3390/biomedicines9101437

Ejemplares similares